Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People whose overall health and ability to carry out daily activities meets a certain minimum level (a score of 2 or less on a standard medical scale used in cancer care)
- People who have a tumour that can be seen and measured, and that needs to be surgically removed in an operating room
- People whose cancer is one of the following types: stomach (gastric), pancreatic, liver or bile duct (hepatobiliary), colorectal, sarcoma, brain, or breast cancer that may involve the lymph nodes under the arm — whether the tumour is the original (primary) cancer or one that has spread (metastatic)
- People who understand the research nature of this study and are willing to sign a written consent form approved by an ethics committee
- People who are able to have a skin prick test done before surgery (after signing the consent form) to check for any sensitivity to a substance called fluorescein, which is used in the trial
Who may not be able to join:
- People with serious uncontrolled illnesses, such as an active infection, heart failure with symptoms, unstable chest pain, irregular heart rhythms, or significant mental health or social circumstances
- People whose kidneys are not working well enough (a specific kidney function measurement called GFR is below 45)
- People whose liver is not working well enough, based on standard scoring measures or abnormal liver blood test results
- People who have a known allergy or previous reaction to fluorescein, or who test positive on the pre-operative skin prick test for fluorescein
- People who are pregnant or breastfeeding (confirmed by a urine pregnancy test before surgery)
- People who are unwilling or unable to follow the requirements of the study protocol
- People who have any other condition that the study doctors consider makes participation unsuitable — for example, certain abnormal heart readings on an electrical heart tracing (ECG), or a condition that needs further heart investigations such as an echocardiogram or stress test
- People for whom surgical removal of the tumour is not considered the appropriate standard treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Emmanuel M Gabriel, M.D., Ph.D., Mayo Clinic
Phone: 904-953-2523
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
1. Tumor vessel identification (# tumor vessels visualized per high power field); 2. Tumor vessel density (# tumor vessels per square cm area observed); 3. Fluorescent dye uptake (# tumor vessels with fluorescent dye uptake and # tumor vessels without dye uptake); 4. Tumor blood flow (velocity, mm/sec)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.